Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Collaboration symbols : Fstx save search
F-star Therapeutics Announces Merck KGaA, Darmstadt, Germany Exercises a Fourth Licensing Option in Immuno-Oncology Collaboration
Published: 2022-01-05 (Crawled : 15:30) - biospace.com/
FSTX | $7.12 0.0% 0
|
Health Technology
|
| O: 1.62%
H: 4.37%
C: -6.36%
star therapeutics germany collaboration license
F-star Therapeutics Announces Collaboration with MSD to Evaluate FS120 in Combination with KEYTRUDA
Published: 2021-08-04 (Crawled : 20:00) - biospace.com/
FSTX | $7.12 0.0% 0
|
Health Technology
|
| O: -1.85%
H: 10.0%
C: 3.58%
collaboration announces collaboration keytruda
IONTAS Collaboration With F-star Enters Oncology Phase 1 Clinical Trial
Published: 2021-06-29 (Crawled : 11:00) - biospace.com/
FSTX | $7.12 0.0% 0
|
Health Technology
|
| O: -0.78%
H: 4.26%
C: -1.68%
phase 1 collaboration trial phase 2 phase 3
Inivata Announces Collaboration with F-star Therapeutics for the use of RaDaRTM Assay
Published: 2021-05-25 (Crawled : 12:00) - biospace.com/
FSTX | $7.12 0.0% 0
|
Health Technology
|
| O: 0.62%
H: 0.49%
C: -2.33%
collaboration announces collaboration
F-star Therapeutics Announces Third Option Exercised by Merck KGaA, Darmstadt, Germany in Immuno-Oncology Collaboration
Published: 2021-04-01 (Crawled : 12:15) - globenewswire.com
FSTX | $7.12 0.0% 0
|
Health Technology
|
| O: 1.48%
H: 0.92%
C: -3.55%
collaboration germany
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.